AMGEN INC (AMGN)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Large insider saleSantos Esteban (officer) sold $11.6M of stock
- Large insider saleSantos Esteban (officer) sold $9.2M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleGordon Murdo (officer) sold $2.3M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-13 | Khosla Rachna | officer | M | 1,252 | 162.6 | $203,575 |
| 2026-08-13 | Khosla Rachna | officer | S | 1,252 | 416.43 | $521,365 |
| 2026-08-11 | Khosla Rachna | officer | S | 2,000 | 412.57 | $825,134 |
| 2026-08-07 | Busch Matthew C. | officer | A | 730 | 0 | $0 |
| 2026-08-07 | ISHRAK OMAR | director | A | 85 | 0 | $0 |
| 2026-08-07 | HOLLEY CHARLES M | director | A | 103 | 0 | $0 |
| 2026-08-07 | Drake Michael V | director | A | 64 | 0 | $0 |
| 2026-08-06 | Miller Derek | officer | M | 2,069 | 162.6 | $336,419 |
| 2026-08-06 | Miller Derek | officer | S | 2,069 | 402.54 | $832,864 |
| 2026-08-06 | Miller Derek | officer | M | 1,821 | 177.46 | $323,155 |
| 2026-08-06 | Miller Derek | officer | S | 1,821 | 402.54 | $733,033 |
| 2026-08-06 | Grygiel Nancy A. | officer | M | 1,970 | 177.46 | $349,596 |
| 2026-08-06 | Grygiel Nancy A. | officer | S | 1,970 | 402.16 | $792,255 |
| 2026-08-06 | Grygiel Nancy A. | officer | M | 1,000 | 177.31 | $177,310 |
| 2026-08-06 | Grygiel Nancy A. | officer | S | 1,000 | 402.16 | $402,160 |
| 2026-05-19 | MILES AMY E | director | A | 665 | 0 | $0 |
| 2026-05-19 | Kullman Ellen Jamison | director | A | 665 | 0 | $0 |
| 2026-05-19 | Klotman Mary E. | director | A | 665 | 0 | $0 |
| 2026-05-19 | Jacks Tyler | director | A | 665 | 0 | $0 |
| 2026-05-19 | ISHRAK OMAR | director | A | 665 | 0 | $0 |
| 2026-05-19 | HOLLEY CHARLES M | director | A | 665 | 0 | $0 |
| 2026-05-19 | Garland Greg C. | director | A | 665 | 0 | $0 |
| 2026-05-19 | ECKERT ROBERT | director | A | 665 | 0 | $0 |
| 2026-05-19 | Druker Brian | director | A | 665 | 0 | $0 |
| 2026-05-19 | Drake Michael V | director | A | 665 | 0 | $0 |
| 2026-05-19 | Austin Wanda M | director | A | 665 | 0 | $0 |
| 2026-05-19 | MILES AMY E | director | A | 665 | 0 | $0 |
| 2026-05-19 | Kullman Ellen Jamison | director | A | 665 | 0 | $0 |
| 2026-05-19 | Klotman Mary E. | director | A | 665 | 0 | $0 |
| 2026-05-19 | Jacks Tyler | director | A | 665 | 0 | $0 |
| 2026-05-19 | ISHRAK OMAR | director | A | 665 | 0 | $0 |
| 2026-05-19 | HOLLEY CHARLES M | director | A | 665 | 0 | $0 |
| 2026-05-19 | Garland Greg C. | director | A | 665 | 0 | $0 |
| 2026-05-19 | ECKERT ROBERT | director | A | 665 | 0 | $0 |
| 2026-05-19 | Druker Brian | director | A | 665 | 0 | $0 |
| 2026-05-19 | Drake Michael V | director | A | 665 | 0 | $0 |
| 2026-05-19 | Austin Wanda M | director | A | 665 | 0 | $0 |
| 2026-05-07 | Busch Matthew C. | officer | F | 41 | 331.11 | $13,576 |
| 2026-05-07 | Santos Esteban | officer | F | 522 | 331.11 | $172,839 |
| 2026-05-07 | REESE DAVID M | officer | F | 556 | 331.11 | $184,097 |
| 2026-05-07 | Miller Derek | officer | F | 151 | 331.11 | $49,998 |
| 2026-05-07 | Khosla Rachna | officer | F | 93 | 331.11 | $30,793 |
| 2026-05-07 | Grygiel Nancy A. | officer | F | 88 | 331.11 | $29,138 |
| 2026-05-07 | Griffith Peter H. | officer | F | 556 | 331.11 | $184,097 |
| 2026-05-07 | Graham Jonathan P | officer | F | 499 | 331.11 | $165,224 |
| 2026-05-07 | Gordon Murdo | officer | F | 615 | 331.11 | $203,633 |
| 2026-05-07 | Bradway Robert A | director | F | 2,079 | 331.11 | $688,378 |
| 2026-05-07 | Bradner James E. | officer | F | 446 | 331.11 | $147,675 |
| 2026-05-07 | Busch Matthew C. | officer | F | 41 | 331.11 | $13,576 |
| 2026-05-07 | Santos Esteban | officer | F | 522 | 331.11 | $172,839 |
Federal contracts
24-month federal obligations: $2,276,291
- 2025-09-04 $2,276,291 · Department of Health and Human Services · SUPPLEMENTAL FUNDING FOR $3,711,014.00 TO CLIN 002, DE-OB $1,434,722.76 IN CANCELING FUNDS UNDER OS241378, ADD ALTERNATE
- 2026-06-02 $0 · Department of Health and Human Services · NO COST EXTENSION CLIN 0001. PERIOD OF PERFORMANCE FOR CLIN 0001 ENDS 28 JUNE 2028. REVISE B.6 ADVANCE UNDERSTANDINGS AN
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 316 views/day vs 90-day median 344.